|
MARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.438250E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.542200E-01 |
| Normal-vs-Stage2 |
5.280800E-01 |
| Normal-vs-Stage3 |
9.529600E-01 |
| Normal-vs-Stage4 |
3.204200E-01 |
| Stage1-vs-Stage2 |
2.336000E-01 |
| Stage1-vs-Stage3 |
5.781400E-01 |
| Stage1-vs-Stage4 |
1.277620E-01 |
| Stage2-vs-Stage3 |
5.493200E-01 |
| Stage2-vs-Stage4 |
9.473400E-01 |
| Stage3-vs-Stage4 |
4.484400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.485900E-02 |
| Normal-vs-AfricanAmerican |
9.807600E-01 |
| Normal-vs-Asian |
8.966200E-01 |
| Caucasian-vs-AfricanAmerican |
2.391200E-01 |
| Caucasian-vs-Asian |
5.505200E-01 |
| AfricanAmerican-vs-Asian |
8.930400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.147700E-02 |
| Normal-vs-Female |
6.572200E-01 |
| Male-vs-Female |
7.086500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.902200E-01 |
| Normal-vs-Extreme_Weight |
5.120300E-03 |
| Normal-vs-Obese |
1.705160E-01 |
| Normal-vs-Extreme_Obese |
2.182400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.617800E-01 |
| Normal_Weight-vs-Obese |
7.195400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.759410E-01 |
| Extreme_Weight-vs-Obese |
2.874200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.825500E-02 |
| Obese-vs-Extreme_Obese |
1.377640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.152200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.891170E-01 |
| Normal-vs-Age(61-80Yrs) |
3.473400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.030310E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.745200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.498600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.768100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.686600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.212300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.179940E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.477840E-03 |
| Normal-VS-Type2 PRCC |
2.018600E-01 |
| Normal-VS-KIRP CIMP |
6.750000E-01 |
| Normal-VS-Unclassified PRCC |
4.961800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.695900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.288200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.778230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.477000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.194960E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.913600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.747600E-02 |
| Normal-vs-N1 |
6.011000E-01 |
| Normal-vs-N2 |
2.673400E-01 |
| N0-vs-N1 |
1.240180E-01 |
| N0-vs-N2 |
5.026200E-01 |
| N1-vs-N2 |
1.518230E-01 |
|
|
